Skip to Content

Jay Keasling, PhD

Professor, Chemical and Biomolecular Engineering and Bioengineering

Bio

Jay Keasling is a pioneer in engineering microbes and metabolism. During the early 2000s, Jay led a UC Berkeley research team to use engineered yeast to synthetically produce artemisinin, the powerful anti-malarial drug. Researchers at the Keasling Lab are now using the same technology to produce other pharmaceuticals, commodity chemicals, and cellulosic biofuels.
Biography

Professor, Department of Chemical & Biomolecular Engineering

Professor, Department of Bioengineering

Philomathia Chair in Alternative Energy

Faculty Senior Scientist, Lawrence Berkeley National Laboratory

CEO, Joint BioEnergy Institute

Jay Keasling is a pioneer in engineering microbes and metabolism. During the early 2000s, Jay led a UC Berkeley research team to use engineered yeast to synthetically produce artemisinin, the powerful anti-malarial drug. Researchers at the Keasling Lab are now using the same technology to produce other pharmaceuticals, commodity chemicals, and cellulosic biofuels.